Rotigotine-

Rotigotine (N-0923) is a non-ergot dopamine agonist used to treat Parkinson's disease and restless legs syndrome via a transdermal patch. It is employed in neuroscience research to study dopaminergic pathways in both in vitro receptor binding assays and in vivo models of movement disorders, with no significant association with drug-induced liver injury.

Product Specifications

CAS Number

99755-59-6

Product Name Alternative

5-HT1A, 5-HT Receptor, AdrenergicReceptor, Adrenergic Receptor, 5HTReceptor, 5-hydroxytryptamine Receptor, 5HT Receptor, D2, D3, dopamine, Dopamine, Dopamine Receptor, DopamineReceptor, Beta Receptor, Inhibitor, N 0437, N 0923, inhibit, N0437, N-0437, N0923, N-0923, Neupro, α2B-adrenergic, Rotigotine, Rotigotine-, SPM 962, SPM962, SPM-962, Serotonin Receptor, receptor

Field of Research

Neuroscience, Pharmacology & Drug Discovery

Purity

98.08% (May vary between batches)

Solubility

10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.34 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:75 mg/mL (237.74 mM) ; Ethanol:59 mg/mL (187.02 mM)